Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
Cesarone MR, Belcaro G, Pellegrini L, Ledda A, Di Renzo A, Vinciguerra G, Ricci A, Gizzi G, Ippolito E, Fano F, Dugall M, Acerbi G, Cacchio M. Cesarone MR, et al. Among authors: acerbi g. Angiology. 2005 Jan-Feb;56(1):1-8. doi: 10.1177/000331970505600101. Angiology. 2005. PMID: 15678250 Clinical Trial.
Circulating endothelial cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with venoruton.
Cesarone MR, Belcaro G, Pellegrini L, Ledda A, Vinciguerra G, Ricci A, Gizzi G, Ippolito E, Fano F, Dugall M, Acerbi G, Cacchio M, Di Renzo A, Hosoi M, Stuard S, Corsi M. Cesarone MR, et al. Among authors: acerbi g. J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):93-8. doi: 10.1177/107424840601100109. J Cardiovasc Pharmacol Ther. 2006. PMID: 16703224 Clinical Trial.
Microcirculatory effects of Viatromb spray gel heparin in chronic venous insufficiency: evaluation of TcPO2 and PCO2--a product evaluation study.
Rosaria Cesarone M, Belcaro G, Errichi S, Pellegrini L, Ledda A, Vinciguerra G, Ricci A, Gizzi G, Ippolito E, Fano F, Dugall M, Acerbi G, Cacchio M, Di Renzo A, Hosoi M, Stuard S, Corsi M. Rosaria Cesarone M, et al. Among authors: acerbi g. Angiology. 2007 Apr-May;58 Suppl 1:21S-26S. doi: 10.1177/0003319706297625. Angiology. 2007. PMID: 17478879 Clinical Trial.
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial.
Incandela L, Belcaro G, Renton S, DeSanctis MT, Cesarone MR, Bavera P, Ippolito E, Bucci M, Griffin M, Geroulakos G, Dugall M, Golden G, Acerbi G. Incandela L, et al. Among authors: acerbi g. J Cardiovasc Pharmacol Ther. 2002 Jan;7 Suppl 1:S7-S10. doi: 10.1177/107424840200700103. J Cardiovasc Pharmacol Ther. 2002. PMID: 12011966 Clinical Trial.
Flight microangiopathy in medium-to-long distance flights: prevention of edema and microcirculation alterations with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective, randomized, controlled trial.
Cesarone MR, Belcaro G, Incandela L, Geroulakos G, Griffin M, Lennox A, DeSanctis MT, Acerbi G. Cesarone MR, et al. Among authors: acerbi g. J Cardiovasc Pharmacol Ther. 2002 Jan;7 Suppl 1:S17-20. doi: 10.1177/107424840200700105. J Cardiovasc Pharmacol Ther. 2002. PMID: 12011968 Clinical Trial.
Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.
Cesarone MR, Incandela L, DeSanctis MT, Belcaro G, Griffin M, Ippolito E, Acerbi G. Cesarone MR, et al. Among authors: acerbi g. J Cardiovasc Pharmacol Ther. 2002 Jan;7 Suppl 1:S21-4. doi: 10.1177/107424840200700106. J Cardiovasc Pharmacol Ther. 2002. PMID: 12011969 Clinical Trial.
Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized trial.
Cesarone MR, Incandela L, DeSanctis MT, Belcaro G, Dugall M, Acerbi G. Cesarone MR, et al. Among authors: acerbi g. J Cardiovasc Pharmacol Ther. 2002 Jan;7 Suppl 1:S25-8. doi: 10.1177/107424840200700107. J Cardiovasc Pharmacol Ther. 2002. PMID: 12011970 Clinical Trial.
HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial.
Belcaro G, Cesarone MR, Bavera P, Ricci A, Renton S, Leon M, Ippolito E, Dugall M, Acerbi G. Belcaro G, et al. Among authors: acerbi g. J Cardiovasc Pharmacol Ther. 2002 Jul;7(3):139-45. doi: 10.1177/107424840200700303. J Cardiovasc Pharmacol Ther. 2002. PMID: 12232562 Clinical Trial.
52 results